Live feed16:45:21·15mINSIDERFilingvia QuantisnowChief Scientific Officer Patil Rajkumar V. was granted 3,363 shares, increasing direct ownership by 20% to 20,030 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.OKYO· OKYO Pharma LimitedHealth CareOriginal source